Gordon Research Conferences
PI_Conferences PI_Conferences_Current
Conference Program
 
Matrix Metalloproteinases
Crucial Components of Molecular Networks and Disease Pathways
May 19-24, 2013
Renaissance Tuscany Il Ciocco Resort
Lucca (Barga), Italy
Chair:
Suneel S. Apte

Vice Chair:
M. Sharon Stack

Related Meeting Information
The Matrix Metalloproteinases Gordon Research Conference was held in conjunction with the Matrix Metalloproteinases Gordon Research Seminar. Please refer to the Matrix Metalloproteinases GRS web page for more information.

Proteases co-evolved with their substrates as integral components of specific networks or pathways in development and homeostasis. Elucidating their role in disease, resulting either from loss of function or over-expression, requires a sophisticated understanding within the context of biological networks. Furthermore, successful development of novel therapies relies on an integrated, multidisciplinary approach to investigating such networks and pathways.

The 2013 GRC on Matrix Metalloproteinases will develop these themes in the context of major functional networks, and will be inclusive of multiple organ/biological systems and a variety of disease pathways. The conference will feature fundamental and applied research on all aspects of MMPs, ADAM, ADAMTS, and astacin metalloproteinases, as well as their natural and synthetic inhibitors to highlight general principles as well as specific properties. The role of these metalloproteinases in molecular maturation and turnover in diverse biological systems and models is a major focus. In addition, disease-causing protease mutations, proteolytic mechanisms in acquired diseases, protease regulatory mechanisms at all levels, structural biology, developmental biology, genetics, and therapeutics will constitute the broad scope of the meeting.

Speakers will summarize the most exciting recent developments in their fields, identify the major unanswered questions, and share novel, unpublished data from their laboratories. The GRC on Matrix Metalloproteinases is an international forum that welcomes junior and established scientists from all disciplines to participate, and features scientists from both academia and industry. All applicants are encouraged to submit abstracts and a significant proportion of the oral program will be selected from submitted abstracts. Poster sessions as well as abundant time for social activities provide excellent opportunities for interactions. The informal nature of the conference promotes interdisciplinary interactions and stimulating discussions in a spirit of collegiality and collaboration.

The 2013 GRC on Matrix Metalloproteinases will again offer a Gordon Research Seminar (GRS) organized along the theme of the GRC, which will be held immediately preceding the GRC on Matrix Metalloproteinases. The GRS is a two-day program designed specifically for junior investigators, such as students, postdocs, and clinical trainees. The 2011 GRS was very successful and the attendees had expressed strong enthusiasm for this activity to continue. The Chair and Vice-chair of the 2013 GRS are Sean Gill (Univ of Washington) and Alisha Mendonsa (Vanderbilt University). The GRS offers unparalleled opportunities for peer-peer interaction, oral and poster presentations, and other activities focused on the needs of junior investigators. It is hoped that all GRS attendees will also participate in the GRC.


Contributors

SUNDAY
4:00 pm - 8:00 pmArrival and Check-in (Check-in Desk Closed 6:00 pm - 7:45 pm)
6:00 pmDinner
7:30 pm - 7:40 pmIntroductory Comments by GRC Site Staff
7:40 pm - 7:45 pmWelcome by GRC Chair and Vice-Chair
7:45 pm - 9:30 pmMetalloproteinase networks: Obvious and unexpected
Discussion Leader: Carl Blobel (Weill Medical College, Cornell University, New York, USA)
7:40 pm - 8:10 pm J. Evan Sadler (Washington University School of Medicine, St. Louis, USA)
"ADAMTS13 and thrombotic microangiopathy"
8:10 pm - 8:20 pm Discussion
8:20 pm - 8:45 pm Stefan Rose-John (Christian-Albrechts-Universität zu Kiel, Kiel, Germany)
"The Role of ADAM17 in Inflammation and Cancer"
8:45 pm - 8:55 pm Discussion
8:55 pm - 9:20 pm Laura Machesky (The Beatson Institute for Cancer Research, Glasgow, UK)
"Tethering of MT1-MMP by the actin cytoskeleton to drive invasion"
9:20 pm - 9:30 pm Discussion
MONDAY
7:30 am - 8:30 amBreakfast
9:00 am - 12:30 pmCell-surface networks and metalloproteinases
Discussion Leader: Yoshifumi Itoh (Kennedy Institute of Rheumatology, Oxford, UK)
9:00 am - 9:20 am Shigeki Higashiyama (Ehime University Graduate School of Medicine Ehime, Japan)
"Ectodomain shedding in EGFR/ligand signaling; regulation, functional implication and imaging"
9:20 am - 9:30 am Discussion
9:30 am - 9:50 am Marie Kveiborg (University of Copenhagen, Copenhagen, Denmark)
"A novel regulator of ADAM17 localization - results from a genome-wide functional screen"
9:50 am - 10:00 am Discussion
10:00 am Group Photo / Coffee Break
10:30 am - 10:50 am Kaisa Lehti (University of Helsinki, Helsinki, Finland)
"MT-MMP-signaling receptor interactions at the interface of cell invasion and growth control"
10:50 am - 11:00 am Discussion
11:00 am - 11:10 am Paolo Mignatti (New York University, New York, USA)
"In Vivo Effects of Mutation of Tyrosine 573 In The Cytoplasmic Tail of Membrane-Type 1 Matrix Metalloproteinase (MT1-MMP)"
11:10 am - 11:15 am Discussion
11:15 am - 11:25 am Hoi Leong Xavier Wong (The University of Hong Kong, Hong Kong, China)
"Functional Crosstalk among MT1-MMP and ADAMs"
11:25 am - 11:30 am Discussion
11:30 am - 11:40 am Camilla Frohlich (University of Copenhagen, Copenhagen, Denmark)
"ADAM12 activates MMP-14, resulting in gelatin degradation"
11:40 am - 11:45 am Discussion
11:45 am - 11:55 am Begonia Diaz (Sanford Burnham Medical Research Institute, La Jolla, USA)
"Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia"
11:55 am - 12:00 pm Discussion
12:00 pm - 12:10 pm Yasuyuki Shitomi (Kennedy Institute of Rheumatology, Oxford, UK)
"ADAM10-dependent DDR1 shedding controls collagen signalling and epithelial cell migration on a collagen matrix"
12:10 pm - 12:15 pm Discussion
12:15 pm - 12:25 pm Alicia G. Arroyo (CNIC, Madrid, Spain)
"EMMPRIN is required for endothelial cell junction integrity"
12:25 pm - 12:30 pm Discussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 5:30 pmPoster Session I: The fundamentals (molecular characterization, structure, mechanisms, developmental biology)
5:30 pm - 7:30 pmMetalloproteinases in Network Assembly and Disassembly
Discussion Leader: Hideaki Nagase (Kennedy Institute of Rheumatology, Oxford, UK)
5:30 pm - 5:50 pm Ulrich auf dem Keller (ETH Zurich, Zurich, Switzerland)
"SkiNterminomics - Dissecting MMP activity in cutaneous wound healing"
5:50 pm - 6:00 pm Discussion
6:00 pm - 6:20 pm Amanda Fosang (University of Melbourne, Melbourne, Australia)
"Bioactivity in an aggrecan 32mer fragment"
6:20 pm - 6:30 pm Discussion
6:30 pm - 6:50 pm Christoph Becker-Pauly (Christian-Albrechts-University Kiel, Kiel, Germany)
"It's Make or Break: Meprin Metalloproteases Induce Collagen Fibril Assembly Thereby Increasing Tensile Strength"
6:50 pm - 7:00 pm Discussion
7:00 pm - 7:10 pm Linda Sandell (Washington University School of Medicine, St. Louis, USA)
"Cartilage-specific deletion of the Site-1 protease in mice results in the specific intracellular entrapment of both type IIB procollagen and ADAMTS3"
7:10 pm - 7:15 pm Discussion
7:15 pm - 7:25 pm Mara Martin Alonso (CNIC, Madrid, Spain)
"The protease MT4-MMP is essential for maturation of the vessel wall and maintenance of vascular smooth muscle cell phenotype and vessel homeostasis in vivo"
7:25 pm - 7:30 pm Discussion
8:00 pmDinner
TUESDAY
7:30 am - 8:30 amBreakfast
9:00 am - 12:30 pmMetalloproteinases and inhibitors in developmental and regenerative networks
Discussion Leader: Alain Colige (University of Liege, Liege, Belgium)
9:00 am - 9:20 am Kiyoji Nishiwaki (Kwansei Gakuin University, Sanda City, Japan)
"Networks of ADAMTS proteases and extracellular matrix"
9:20 am - 9:30 am Discussion
9.30 am - 9:50 am Dirk Hubmacher (Lerner Research Institute, Cleveland Clinic, Cleveland, USA)
"Networks comprising ADAMTS proteases, ADAMTS-like proteins and microfibrils in connective tissue disorders"
9.50 am - 10:00 am Discussion
10:00 am Coffee Break
10:30 am - 10:50 am Rama Khokha (Ontario Cancer Institute, Toronto, Canada)
"Lessons from mice with compound TIMP deficiencies"
10:50 am - 11:00 am Discussion
11:00 am - 11:20 am Stephen J. Weiss (University of Michigan, Ann Arbor, USA)
"MT1-MMP -Directed Stem Cell Fate: The Pericellular-Nuclear Matrix Axis"
11:20 am - 11:30 am Discussion
11:30 am - 11:40 am Walter Stocker (University of Mainz, Germany)
"A proteolytic web controls fertilization of the mammalian egg"
11:40 am - 11:45 am Discussion
11:45 am - 11:55 am Lieve K. Moons (KU Leuven, Belgium)
"Co-involvement of MMP-2 and MMP-14 during axonal outgrowth"
11:55 am - 12:00 pm Discussion
12:00 pm - 12:10 pm Noriko Aramaki-Hattori (Keio University, Tokyo, Japan)
"A new conditional mouse allele for Adamts9 identifies its essential role in interdigital web regression"
12:10 pm - 12:15 pm Discussion
12:15 pm - 12:25 pm Carolyn Dancevic (Deakin University, Geelong, Australia)
"Sonic hedgehog patterning is regulated by ADAMTS5 upstream of TGF-β dependent pathways during early development in the zebrafish"
12:25 pm - 12:30 pm Discussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 5:30 pmPoster Session I: Metalloproteinase fundamentals (molecular characterization, structure, mechanisms, developmental biology)
5:30 pm - 7:30 pmExplaining how metalloproteinases work
Discussion Leader: F. Xavier Gomis-Ruth (Molecular Biology Institute of Barcelona, Barcelona, Spain)
5:30 pm - 5:50 pm F. Xavier Gomis-Ruth (Molecular Biology Institute of Barcelona, Barcelona, Spain)
"Structure of alpha2-macroglobulin, a Venus flytrap pan-protease inhibitor"
5:50 pm - 6:00 pm Discussion
6:00 pm - 6:20 pm Catherine Moali (University of Lyon, Lyon, France)
"Roles and regulation of BMP-1/tolloid-like proteases: collagen maturation and beyond"
6:20 pm - 6:30 pm Discussion
6:30 pm - 6:50 pm Ghislain Opdenakker (Rega Institute, Leuven, Belgium)
"Novel insights into the model structure of intact MMP-9 monomers and multimers and functional consequences"
6:50 pm - 7:00 pm Discussion
7:00 pm - 7:10 pm Dmitriy Minond (Torrey Pines Institute for Molecular Studies, La Jolla, USA)
"Effect of Substrate and Enzyme Glycosylation on ADAM17 Activity and Inhibition"
7:10 pm - 7:15 pm Discussion
7:15 pm - 7:25 pm Steven Van Doren (University of Missouri, USA)
"Structural Basis of Interactions of Soluble MMPs with Components of Cell Surfaces"
7:25 pm - 7:30 pm Discussion
8:00 pmDinner
WEDNESDAY
7:30 am - 8:30 amBreakfast
9:00 am - 12:30 pmMetalloproteinases in cancer networks
Discussion Leaders: M. Sharon Stack (University of Notre Dame, USA) and James Quigley (The Scripps Research Institute, La Jolla, USA)
9:00 am - 9:20 am Howard Crawford (Mayo Clinic, Jacksonville, Florida, USA)
"ADAMs as the Gatekeepers of Pancreatic Tumor Cell Differentiation"
9:20 am - 9:30 am Discussion
9:30 am - 9:50 am Motoharu Seiki (University of Tokyo, Tokyo, Japan)
"MT1-MMP triggers a vicious cycle of oncogenic signals"
9:50 am - 10:00 am Discussion
10:00 am Coffee Break
10:30 am - 10:50 am Cornelia Mauch (Uniklinik Koln, Cologne, Germany)
"MT1-MMP in cancer"
10:50 am - 11:00 am Discussion
11:00 am - 11:20 am Angeles Garcia-Pardo (CSIC, Madrid, Spain)
"Multiple roles of MMP-9 in the pathogenesis of B-cell chronic lymphocytic leukemia"
11:20 am - 11:30 am Discussion
11:30 am - 11:40 am Anna Juncker-Jensen (The Scripps Research Institute, La Jolla, USA)
"Tumor-produced MMP-1 facilitates intravasation and dissemination of human carcinoma cells by modulating the microarchitecture and permeability of intratumoral vasculature"
11:40 am - 11:45 am Discussion
11:45 am - 11:55 am Katerina Wolf (Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands)
"Limits of tumor cell migration: control by space and nuclear deformation and modulation by traction and ECM degradation"
11:55 am - 12:00 pm Discussion
12:00 pm - 12:10 pm Anna Zolkiewska (Kansas State University, Manhattan, KS, USA)
"ADAM12 is a breast cancer stem cell-associated gene"
12:10 pm - 12:15 pm Discussion
12:15 pm - 12:25 pm Joaquin Arribas (Vall d'Hebron University Hospital Research Institute, Barcelona, Spain)
"ADAM17 mediates the protumorigenic effect of p95HER2-induced senescent cells"
12:25 pm - 12:30 pm Discussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 5:30 pmPoster Session II: The translational and translated (Disease models and pathways, biomarkers, probes, inhibitors, treatments)
5:30 pm - 7:30 pmMetalloproteinase inhibition and targeting-thinking anew
Discussion Leader: Gillian Murphy (Cambridge University, Cambridge, UK)
5:30 pm - 5:50 pm Carl Blobel (Hospital for Special Surgery, New York, USA)
"ADAM17, a key regulator of EGFR signaling and TNF-dependent pathologies"
5:50 pm - 6:00 pm Discussion
6:00 pm - 6:20 pm Linda Troeberg (Kennedy Institute for Rheumatology, Oxford, UK)
"LRP-1 regulates extracellular matrix degradation by controlling levels of metalloproteinases and their inhibitors"
6:20 pm - 6:30 pm Discussion
6:30 pm - 6:50 pm Christian Ries (University of Munich, Munich, Germany)
"TIMP-1 and its networks with miRNA"
6:50 pm - 7:00 pm Discussion
7:00 pm - 7:10 pm Achim Kruger (Klinikum rechts der Isar - TUM, Munich, Germany)
"Tissue inhibitor of metalloproteinases (TIMP)-1 creates a dominant liver-specific pre-metastatic niche through SDF-1-mediated neutrophil recruitment"
7:10 pm - 7:15 pm Discussion
7:15 pm - 7:25 pm Andreas Herrlich (Harvard Medical School, Boston, USA)
"Regulation of ectodomain cleavage by substrate selecting signaling pathways"
7:25 pm - 7:30 pm Discussion
7:30 pm - 8:00 pmBusiness Meeting (chaired by M. Sharon Stack, 2015 GRC chair)
Nominations for the next Vice Chair; Fill out Conference Evaluation Forms; Discuss future Site & Scheduling preferences; Election of the next Vice Chair
8:00 pmDinner
THURSDAY
7:30 am - 8:30 amBreakfast
9:00 am - 12:30 pmDisease Networks: Metalloproteinases as novel mediators and potential targets
Discussion Leader: Alicia G. Arroyo (CNIC, Madrid, Spain)
9:00 am - 9:20 am Yasunori Okada (Keio University, Tokyo, Japan)
"MMPs in diagnosis and pathogenesis of cardiovascular disease"
9:20 am - 9:30 am Discussion
9:30 am - 9:50 am Wei Kong (Peking University Health Science Center, Beijing, P.R. China)
"ADAMTS-7 in vascular remodelling and angiogenesis"
9:50 am - 10:00 am Discussion
10:00 am Coffee Break
10:30 am - 10:50 am Juliane Bubeck Wardenburg (University of Chicago, Chicago, USA)
"ADAM10 - A Versatile Tool for a Bacterial Cytotoxin"
10:50 am - 11:00 am Discussion
11:00 am - 11:20 am Caroline Owen (Brigham and Women's Hospital / Harvard Medical School, Boston, USA)
"Anti-inflammatory activities for ADAM8 in allergic airway inflammation"
11:20 am - 11:30 am Discussion
11:30 am - 11:50 am Christopher Overall (University of British Columbia, Vancouver, Canada)
"Moonlighting MMPs: The Ins and Outs of MMP-12"
11:50 am - 12:00 pm Discussion
12:00 pm - 12:10 pm Roosmarijn Vandenbroucke (VIB - Ghent University, Belgium)
"Role of matrix metalloproteinases in inflammation-induced epithelial barrier disruption"
12:10 pm - 12:15 pm Discussion
12:15 pm - 12:25 pm E. Sachiko Seilie (University of Washington, Seattle, USA)
"Matrix Metalloproteinase 13a is an Early Host-Protective Determinant in Tuberculous Infection"
12:25 pm - 12:30 pm Discussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 5:30 pmPoster Session II: The translational and translated (Disease models and pathways, probes, inhibitors, treatments)
5:30 pm - 7:30 pmFrom Networks and Pathways to New Treatments
Discussion Leader: Rafael Fridman (Wayne State University, Detroit, USA)
5:30 pm - 5:50 pm Jonathan Larkin (GlaxoSmithKline, King of Prussia, USA)
"Forging a translational pathway to clinical development: Aggrecanase neutralizing mAbs for osteoarthritis disease modification"
5:50 pm - 6:00 pm Discussion
6:00 pm - 6:10 pm Riccardo Chiusaroli (Rottapharm SPA, Monza, Italy)
"Interfering with ADAMTS5's biological activity via a recombinant mAb ameliorates disease progression in a spontaneous murine model of osteoarthritis"
6:10 pm - 6:15 pm Discussion
6:15 pm - 6:25 pm Kazuyo Kaneko (Kennedy Institute of Rheumatology, Oxford, UK)
"MT1-MMP: a new target to improve rheumatoid arthritis therapy"
6:25 pm - 6:30 pm Discussion
6:30 pm - 6:40 pm Satsuki Mochizuki (Keio University, Tokyo, Japan)
"Development of human anti-ADAM28 neutralizing antibodies that inhibit cancer cell growth and metastasis"
6:40 pm - 6:45 pm Discussion
6:45 pm - 7:30 pm General Discussion: "Monoclonal Antibodies as Metalloproteinase Therapeutics"
Moderators: R. Fridman (Wayne State University, Detroit, MI, USA), G. Murphy (Cambridge University, UK), J. Larkin (GlaxoSmithKline, Prince Of Prussia, NJ, USA), and Y. Okada (Keio University, Tokyo, Japan)
8:00 pmDinner
FRIDAY
7:30 am - 8:30 amBreakfast
9:00 amDeparture

Funding for this conference was made possible (in part) by 1R13CA176706-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Last Updated: May 20, 2013
 
© 2013 Gordon Research Conferences. All Rights Reserved. Search | Contact | Terms of Use | Privacy Policy | Follow us: Facebook Twitter